Human Cytomegalovirus US28 Found in Glioblastoma Promotes an Invasive and Angiogenic Phenotype
- 30 October 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (21), 6643-6653
- https://doi.org/10.1158/0008-5472.can-11-0744
Abstract
Human cytomegalovirus (HCMV) infections are seen often in glioblastoma multiforme (GBM) tumors, but whether the virus contributes to GBM pathogenesis is unclear. In this study, we explored an oncogenic role for the G-protein–coupled receptor-like protein US28 encoded by HCMV that we found to be expressed widely in human GBMs. Immunohistochemical and reverse transcriptase PCR approaches established that US28 was expressed in approximately 60% of human GBM tissues and primary cultures examined. In either uninfected GBM cells or neural progenitor cells, thought to be the GBM precursor cells, HCMV infection or US28 overexpression was sufficient to promote secretion of biologically active VEGF and to activate multiple cellular kinases that promote glioma growth and invasion, including phosphorylated STAT3 (p-STAT3) and endothelial nitric oxide synthase (e-NOS). Consistent with these findings, US28 overexpression increased primary GBM cell invasion in Matrigel. Notably, this invasive phenotype was further enhanced by exposure to CCL5/RANTES, a US28 ligand, associated with poor patient outcome in GBM. Conversely, RNA interference–mediated knockdown of US28 in human glioma cells persistently infected with HCMV led to an inhibition in VEGF expression and glioma cell invasion in response to CCL5 stimulation. Analysis of clinical GBM specimens further revealed that US28 colocalized in situ with several markers of angiogenesis and inflammation, including VEGF, p-STAT3, COX2, and e-NOS. Taken together, our results indicate that US28 expression from HCMV contributes to GBM pathogenesis by inducing an invasive, angiogenic phenotype. In addition, these findings argue that US28–CCL5 paracrine signaling may contribute to glioma progression and suggest that targeting US28 may provide therapeutic benefits in GBM treatment. Cancer Res; 71(21); 6643–53. ©2011 AACR.Keywords
Other Versions
This publication has 23 references indexed in Scilit:
- Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating PhenotypeClinical Cancer Research, 2011
- Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasivenessJournal of Neuro-Oncology, 2007
- Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastomaProceedings of the National Academy of Sciences of the United States of America, 2007
- Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesisProceedings of the National Academy of Sciences, 2006
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisCancer Cell, 2006
- Using DNA microarray to study human cytomegalovirus gene expressionJournal of Virological Methods, 2006
- HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networksTrends in Pharmacological Sciences, 2006
- The Human Cytomegalovirus Chemokine Receptor US28 Mediates Vascular Smooth Muscle Cell MigrationCell, 1999
- Expression of nitric oxide synthase in the cerebral microvasculature after traumatic brain injury in the ratBrain Research, 1997
- Expression of nitric oxide synthase in human central nervous system tumors.1995